195
Views
9
CrossRef citations to date
0
Altmetric
Review

Evaluating the risk of manganese-induced neurotoxicity of parenteral nutrition: review of the current literature

, , ORCID Icon, , , , , & ORCID Icon show all
Pages 581-593 | Received 11 Dec 2020, Accepted 19 Feb 2021, Published online: 04 Mar 2021

References

  • Bhattacharya PT, Misra SR, Hussain M. Nutritional aspects of essential trace elements in oral health and disease: an extensive review. Scientifica (Cairo). 2016;2016:5464373.
  • Druyan ME, Compher C, Boullata JI, et al. Clinical guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients: applying the GRADE system to development of A.S.P.E.N. clinical guidelines. JPEN J Parenter Enteral Nutr. 2012 Jan;36(1):77–80.
  • Blaauw R, Osland E, Sriram K, et al. Parenteral provision of micronutrients to adult patients: an expert consensus paper. JPEN J Parenter Enteral Nutr. 2019 Mar;43(Suppl 1):S5–S23.
  • Hardy G, Wong T, Morrissey H, et al. Parenteral provision of micronutrients to pediatric patients: an international expert consensus paper. JPEN J Parenter Enteral Nutr. 2020 Sep; 44(Suppl 2):S5–S23.
  • Sasabuchi Y, Ono S, Kamoshita S, et al. Clinical impact of prescribed doses of nutrients for patients exclusively receiving total parenteral nutrition in Japanese hospitals: A retrospective cohort study. JPEN J Parenter Enteral Nutr. 2020 Oct 21;
  • Domellof M, Szitanyi P, Simchowitz V, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: iron and trace minerals. Clin Nutr. 2018 Dec;37(6 Pt B):2354–2359.
  • Joffe A, Anton N, Lequier L, et al. Nutritional support for critically ill children. Cochrane Database Syst Rev. 2016 May;27(5):CD005144.
  • Mirtallo JM. Perspectives on parenteral micronutrient shortages. Nutr Clin Pract. 2015 Feb;30(1):86–91.
  • Buchman AL, Howard LJ, Guenter P, et al. Micronutrients in parenteral nutrition: too little or too much? The past, present, and recommendations for the future. Gastroenterology. 2009 Nov;137(5 Suppl):S1–6.
  • Amin H, Shawkat A. Manganese toxicity complicating parenteral nutrition. Am J Ther. 2019 Apr;27(3):e303-e304..
  • Aschner JL, Anderson A, Slaughter JC, et al. Neuroimaging identifies increased manganese deposition in infants receiving parenteral nutrition. Am J Clin Nutr. 2015 Dec;102(6):1482–1489.
  • Aschner JL, Aschner M. Nutritional aspects of manganese homeostasis. Mol Aspects Med. 2005 Aug-Oct;26(4–5):353–362.
  • Mehta R, Reilly JJ. Manganese levels in a jaundiced long-term total parenteral nutrition patient: potentiation of haloperidol toxicity? Case report and literature review. JPEN J Parenter Enteral Nutr. 1990 Jul-Aug;14(4):428–430.
  • Alves G, Thiebot J, Tracqui A, et al. Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. JPEN J Parenter Enteral Nutr. 1997 Jan-Feb;21(1):41–45.
  • Ikeda S, Sera Y, Yoshida M, et al. Manganese deposits in patients with biliary atresia after hepatic porto-enterostomy. J Pediatr Surg. 2000 Mar;35(3):450–453.
  • Balachandran RC, Mukhopadhyay S, McBride D, et al. Brain manganese and the balance between essential roles and neurotoxicity. J Biol Chem. 2020 Mar;295(19):6312-6329.
  • Aschner M, Erikson K. Manganese. Adv Nutr. 2017 May;8(3):520–521.
  • Archibald FS, Tyree C. Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch Biochem Biophys. 1987 Aug 1;256(2):638–650.
  • O’Neal SL, Zheng W. Manganese toxicity upon overexposure: a decade in review. Curr Environ Health Rep. 2015 Sep;2(3):315–328.
  • Miah MR, Ijomone OM, Okoh COA, et al. The effects of manganese overexposure on brain health. Neurochem Int. 2020 Jan 20; 135:104688.
  • Racette BA, Criswell SR, Lundin JI, et al. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology. 2012 Oct;33(5):1356–1361.
  • Criswell SR, Warden MN, Searles Nielsen S, et al. Selective D2 receptor PET in manganese-exposed workers. Neurology. 2018 Sep 11; 91(11):e1022–e1030.
  • Discalzi G, Pira E, Herrero Hernandez E, et al. Occupational Mn parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation. Neurotoxicology. 2000 Oct;21(5):863–866.
  • Racette BA, Searles Nielsen S, Criswell SR, et al. Dose-dependent progression of parkinsonism in manganese-exposed welders. Neurology. 2017 Jan 24; 88(4):344–351.
  • Lucchini RG, Guazzetti S, Zoni S, et al. Neurofunctional dopaminergic impairment in elderly after lifetime exposure to manganese. Neurotoxicology. 2014; 45:309–317.
  • Han I, Richner D, An Han H, et al. Evaluation of metal aerosols in four communities adjacent to metal recyclers in Houston, Texas, USA. J Air Waste Manag Assoc. 2020 May;70(5):568–579.
  • ALC DS, Urbano MR, ACB AL, et al. Blood manganese levels and associated factors in a population-based study in Southern Brazil. J Toxicol Environ Health A. 2017;80(19–21):1064–1077.
  • Bowler RM, Beseler CL, Gocheva VV, et al. Environmental exposure to manganese in air: associations with tremor and motor function. Sci Total Environ. 2016 Jan 15; 541:646–654.
  • Martins AC, Krum BN, Queiros L, et al. Manganese in the diet: bioaccessibility, adequate intake, and neurotoxicological effects. J Agric Food Chem. 2020 Apr; 68(46):12893-12903.
  • Khan K, Wasserman GA, Liu X, et al. Manganese exposure from drinking water and children’s academic achievement. Neurotoxicology. 2012 Jan;33(1):91–97.
  • Oulhote Y, Mergler D, Barbeau B, et al. Neurobehavioral function in school-age children exposed to manganese in drinking water. Environ Health Perspect. 2014 Dec;122(12):1343–1350.
  • Martins AC Jr., Morcillo P, Ijomone OM, et al. New insights on the role of manganese in Alzheimer’s Disease and Parkinson’s Disease. Int J Environ Res Public Health. 2019 Sep 22; 16:19.
  • Kwakye GF, Paoliello MM, Mukhopadhyay S, et al. Manganese-induced Parkinsonism and Parkinson’s disease: shared and distinguishable features. Int J Environ Res Public Health. 2015 Jul 6; 12(7):7519–7540.
  • Dickerson RN. Manganese intoxication and parenteral nutrition. Nutrition. 2001 Jul-Aug;17(7–8):689–693.
  • Harischandra DS, Ghaisas S, Zenitsky G, et al. Manganese-induced neurotoxicity: new insights into the triad of protein misfolding, mitochondrial impairment, and neuroinflammation. Front Neurosci. 2019;13:654.
  • Milatovic D, Yin Z, Gupta RC, et al. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol Sci. 2007 Jul;98(1):198–205.
  • Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018 May;15:490–503.
  • Martinez-Finley EJ, Gavin CE, Aschner M, et al. Manganese neurotoxicity and the role of reactive oxygen species. Free Radic Biol Med. 2013; 62:65–75.
  • Bornhorst J, Chakraborty S, Meyer S, et al. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of alpha-synuclein in C. elegans. Metallomics. 2014 Mar;6(3):476–490.
  • Zhang F, Xu Z, Gao J, et al. In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. Environ Toxicol Pharmacol. 2008 Sep;26(2):232–236.
  • Gavin CE, Gunter KK, Gunter TE. Mn2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicol Appl Pharmacol. 1992 Jul;115(1):1–5.
  • Yin Z, Aschner JL, Dos Santos AP, et al. Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures. Brain Res. 2008 Apr 8; 1203:1–11.
  • A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The huntington’s disease collaborative research group. Cell. 1993 Mar 26; 72(6):971–983.
  • Ijomone OM, Aluko OM, Okoh COA, et al. Role for calcium signaling in manganese neurotoxicity. J Trace Elem Med Biol. 2019; 56:146–155.
  • Angeli S, Barhydt T, Jacobs R, et al. Manganese disturbs metal and protein homeostasis in Caenorhabditis elegans. Metallomics. 2014 Oct;6(10):1816–1823.
  • Erikson KM, Syversen T, Aschner JL, et al. Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ Toxicol Pharmacol. 2005 May;19(3):415–421.
  • Venkataramani V, Doeppner TR, Willkommen D, et al. Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin. J Neurochem. 2018 Dec;147(6):831–848.
  • Martins AC Jr., Gubert P, Villas Boas GR, et al. Manganese-induced neurodegenerative diseases and possible therapeutic approaches. Expert Rev Neurother. 2020 Nov;20(11):1109–1121.
  • Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010 Jan 28;362(4):329–344.
  • Guilarte TR, Burton NC, Verina T, et al. Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. J Neurochem. 2008 Jun;105(5):1948–1959.
  • Guilarte TR. APLP1, Alzheimer’s-like pathology and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. Neurotoxicology. 2010 Sep;31(5):572–574.
  • Harischandra DS, Ghaisas S, Rokad D, et al. Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson’s disease: relevance to alpha-synuclein misfolding in metal neurotoxicity. Neurotoxicology. 2018; 64:267–277.
  • Harischandra DS, Jin H, Anantharam V, et al. alpha-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson’s disease. Toxicol Sci. 2015 Feb;143(2):454–468.
  • Cai T, Yao T, Zheng G, et al. Manganese induces the overexpression of alpha-synuclein in PC12 cells via ERK activation. Brain Res. 2010 Nov 4; 1359:201–207.
  • Ma X, Han J, Wu Q, et al. Involvement of dysregulated Wip1 in manganese-induced p53 signaling and neuronal apoptosis. Toxicol Lett. 2015 May 19; 235(1):17–27.
  • Ling J, Yang S, Huang Y, et al. Identifying key genes, pathways and screening therapeutic agents for manganese-induced Alzheimer disease using bioinformatics analysis. Medicine (Baltimore). 2018 Jun;97(22):e10775.
  • Tidball AM, Bryan MR, Uhouse MA, et al. A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington’s disease. Hum Mol Genet. 2015 Apr 1; 24(7):1929–1944.
  • Bryan MR, Nordham KD, Rose DIR, et al. Manganese acts upon insulin/IGF receptors to phosphorylate AKT and increase glucose uptake in huntington’s disease cells. Mol Neurobiol. 2020 Mar;57(3):1570–1593.
  • Cheng H, Xia B, Su C, et al. PI3K/Akt signaling pathway and Hsp70 activate in hippocampus of rats with chronic manganese sulfate exposure. J Trace Elem Med Biol. 2018; 50:332–338.
  • Bae JH, Jang BC, Suh SI, et al. Manganese induces inducible nitric oxide synthase (iNOS) expression via activation of both MAP kinase and PI3K/Akt pathways in BV2 microglial cells. Neurosci Lett. 2006 May 1; 398(1–2):151–154.
  • Bryan MR, Uhouse MA, Nordham KD, et al. Phosphatidylinositol 3 kinase (PI3K) modulates manganese homeostasis and manganese-induced cell signaling in a murine striatal cell line. Neurotoxicology. 2018 Jan; 64:185–194.
  • Dao DT, Anez-Bustillos L, Cho BS, et al. Assessment of micronutrient status in critically ill children: challenges and opportunities. Nutrients. 2017 Oct 28; 9:11.
  • Shenkin A. Vitamin and essential trace element recommendations during intravenous nutrition: theory and practice. Proc Nutr Soc. 1986 Sep;45(3):383–390.
  • van Goudoever JB, Carnielli V, Darmaun D, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: amino acids. Clin Nutr. 2018 Dec;37(6 Pt B):2315–2323.
  • Kurkus J, Alcock NW, Shils ME. Manganese content of large-volume parenteral solutions and of nutrient additives. JPEN J Parenter Enteral Nutr. 1984 May-Jun;8(3):254–257.
  • Claus Henn B, Ettinger AS, Schwartz J, et al. Early postnatal blood manganese levels and children’s neurodevelopment. Epidemiology. 2010 Jul;21(4):433–439.
  • Erikson KM, Thompson K, Aschner J, et al. Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther. 2007 Feb;113(2):369–377.
  • Srikrishnaraj A, Chambers K, South C, et al. Trace elements’ contamination of pediatric parenteral nutrition solutions in Canada: A cause for concern. JPEN J Parenter Enteral Nutr. 2020 Apr;45(2):347-356.
  • Greene E, Shokur R, Brown L, et al. Incidence of Hypermanganesemia in children who are administered parenteral nutrition. JPEN J Parenter Enteral Nutr. 2016 Aug;40(6):766–767.
  • Koletzko B, Goulet O, Hunt J, et al. 1. guidelines on paediatric parenteral nutrition of the European society of paediatric gastroenterology, hepatology and nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005 Nov;41(Suppl 2):S1–87.
  • Smith EA, Newland P, Bestwick KG, et al. Increased whole blood manganese concentrations observed in children with iron deficiency anaemia. J Trace Elem Med Biol. 2013 Jan;27(1):65–69.
  • Hsieh CT, Liang JS, Peng SS, et al. Seizure associated with total parenteral nutrition-related hypermanganesemia. Pediatr Neurol. 2007 Mar;36(3):181–183.
  • Fell JM, Reynolds AP, Meadows N, et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet. 1996 May 4; 347(9010):1218–1221.
  • Santos D, Batoreu C, Mateus L, et al. Manganese in human parenteral nutrition: considerations for toxicity and biomonitoring. Neurotoxicology. 2014; 43:36–45.
  • Slicker J, Vermilyea S. Pediatric parenteral nutrition: putting the microscope on macronutrients and micronutrients. Nutr Clin Pract. 2009 Aug-Sep;24(4):481–486.
  • Charney PJ. American society for P, enteral nutrition aluminum task F. A.s.p.e.N. Statement on aluminum in parenteral nutrition solutions. Nutr Clin Pract. 2004 Aug;19(4):416–417.
  • Subcommittee ASPENCPCS. A.S.P.E.N. parenteral nutrition trace element product shortage considerations. Nutr Clin Pract. 2014 Apr; 29(2):249–251.
  • Hardy G. Manganese in parenteral nutrition: who, when, and why should we supplement? Gastroenterology. 2009 Nov;137(5 Suppl):S29–35.
  • Hardy IJ, Gillanders L, Hardy G. Is manganese an essential supplement for parenteral nutrition? Curr Opin Clin Nutr Metab Care. 2008 May;11(3):289–296.
  • Manganese LC. Provision in parenteral nutrition: an update. Nutr Clin Pract. 2018 Jun;33(3):404–418.
  • Peres TV, Schettinger MR, Chen P, et al. “manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies”. BMC Pharmacol Toxicol. 2016 Nov 4; 17(1):57.
  • Baker B, Ali A, Isenring L. Recommendations for manganese supplementation to adult patients receiving long-term home parenteral nutrition: an analysis of the supporting evidence. Nutr Clin Pract. 2016 Apr;31(2):180–185.
  • Pluhator-Murton MM, Fedorak RN, Audette RJ, et al. Trace element contamination of total parenteral nutrition. 2. Effect of storage duration and temperature. JPEN J Parenter Enteral Nutr. 1999 Jul-Aug;23(4):228–232.
  • Olson LM, Wieruszewski PM, Jannetto PJ, et al. Quantitative Assessment of Trace-Element Contamination in Parenteral Nutrition Components. JPEN J Parenter Enteral Nutr. 2019 Nov;43(8):970–976.
  • Iinuma Y, Kubota M, Uchiyama M, et al. Whole-blood manganese levels and brain manganese accumulation in children receiving long-term home parenteral nutrition. Pediatr Surg Int. 2003 Jun;19(4):268–272.
  • Komaki H, Maisawa S, Sugai K, et al. Tremor and seizures associated with chronic manganese intoxication. Brain Dev. 1999 Mar;21(2):122–124.
  • Siepler JK, Nishikawa RA, Diamantidis T, et al. Asymptomatic hypermanganesemia in long-term home parenteral nutrition patients. Nutr Clin Pract. 2003 Oct;18(5):370–373.
  • Chalela JA, Bonillha L, Neyens R, et al. Manganese encephalopathy: an under-recognized condition in the intensive care unit. Neurocrit Care. 2011 Jun;14(3):456–458.
  • Ejima A, Imamura T, Nakamura S, et al. Manganese intoxication during total parenteral nutrition. Lancet. 1992 Feb 15; 339(8790):426.
  • Reimund JM, Dietemann JL, Warter JM, et al. Factors associated to hypermanganesemia in patients receiving home parenteral nutrition. Clin Nutr. 2000 Oct;19(5):343–348.
  • Taylor S, Manara AR. Manganese toxicity in a patient with cholestasis receiving total parenteral nutrition. Anaesthesia. 1994 Nov;49(11):1013.
  • Reynolds N, Blumsohn A, Baxter JP, et al. Manganese requirement and toxicity in patients on home parenteral nutrition. Clin Nutr. 1998 Oct;17(5):227–230.
  • Mirowitz SA, Westrich TJ. Basal ganglial signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology. 1992 Nov;185(2):535–536.
  • Mirowitz SA, Westrich TJ, Hirsch JD. Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology. 1991 Oct;181(1):117–120.
  • Fitzgerald K, Mikalunas V, Rubin H, et al. Hypermanganesemia in patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1999 Nov-Dec;23(6):333–336.
  • Bertinet DB, Tinivella M, Balzola FA, et al. Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2000 Jul-Aug;24(4):223–227.
  • Walter E, Alsaffar S, Livingstone C, et al. Manganese toxicity in critical care: case report, literature review and recommendations for practice. J Intensive Care Soc. 2016 Aug;17(3):252–257.
  • Takagi Y, Okada A, Sando K, et al. Evaluation of indexes of in vivo manganese status and the optimal intravenous dose for adult patients undergoing home parenteral nutrition. Am J Clin Nutr. 2002 Jan;75(1):112–118.
  • Jin J, Mulesa L, Carrilero Rouillet M. Trace elements in parenteral nutrition: considerations for the prescribing clinician. Nutrients. 2017 Apr 28;9:5.
  • Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004 Nov-Dec;28(6):S39–70.
  • Vanek VW, Borum P, Buchman A, et al. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. Nutr Clin Pract. 2012 Aug;27(4):440–491.
  • Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr. 2009 Aug;28(4):387–400.
  • Braga M, Ljungqvist O, Soeters P, et al. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr. 2009 Aug;28(4):378–386.
  • Staun M, Pironi L, Bozzetti F, et al. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr. 2009 Aug;28(4):467–479.
  • Osland EJ, Ali A, Isenring E, et al. Australasian society for parenteral and enteral nutrition guidelines for supplementation of trace elements during parenteral nutrition. Asia Pac J Clin Nutr. 2014;23(4):545–554.
  • Erikson KM, Shihabi ZK, Aschner JL, et al. Manganese accumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol Trace Elem Res. 2002 Summer; 87(1–3):143–156.
  • Dietemann JL, Reimund JM, Diniz RL, et al. High signal in the adenohypophysis on T1-weighted images presumably due to manganese deposits in patients on long-term parenteral nutrition. Neuroradiology. 1998 Dec;40(12):793–796.
  • Nagatomo S, Umehara F, Hanada K, et al. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci. 1999 Jan 1; 162(1):102–105.
  • Wardle CA, Forbes A, Roberts NB, et al. Hypermanganesemia in long-term intravenous nutrition and chronic liver disease. JPEN J Parenter Enteral Nutr. 1999 Nov-Dec;23(6):350–355.
  • O’Donnell K, Radigan A. Hypermanganesemia in an acute care setting. Nutr Clin Pract. 2003 Oct;18(5):374–376.
  • Kamata N, Oshitani N, Oiso R, et al. Crohn’s disease with Parkinsonism due to long-term total parenteral nutrition. Dig Dis Sci. 2003 May;48(5):992–994.
  • McKinney AM, Filice RW, Teksam M, et al. Diffusion abnormalities of the globi pallidi in manganese neurotoxicity. Neuroradiology. 2004 Apr;46(4):291–295.
  • Howard L, Ashley C, Lyon D, et al. Autopsy tissue trace elements in 8 long-term parenteral nutrition patients who received the current U.S. food and drug administration formulation. JPEN J Parenter Enteral Nutr. 2007 Sep-Oct;31(5):388–396.
  • Abdalian R, Saqui O, Fernandes G, et al. Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition. JPEN J Parenter Enteral Nutr. 2013 Jul;37(4):538–543.
  • Jin J, Saqui O, Allard JP. Effect of discontinuation of manganese supplementation from home parenteral nutrition solutions on whole-blood levels and magnetic resonance imaging of the brain: A 5-year cohort study. JPEN J Parenter Enteral Nutr. 2018 Jan;42(1):164–170.
  • Dastych M, Dastych M Jr., Senkyrik M. Manganese in whole blood and hair in patients with long-term home parenteral nutrition. Clin Lab. 2016;62(1–2):173–177.
  • Kirk C, Gemmell L, Lamb CA, et al. Elevated whole-blood manganese levels in adult patients prescribed “manganese-free” home parenteral nutrition. Nutr Clin Pract. 2020 Dec; 35(6):1138–1142.
  • Crossgrove J, Zheng W. Manganese toxicity upon overexposure. NMR Biomed. 2004 Dec;17(8):544–553.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.